Radiopharma execs warn that lutetium could be at risk of shortage

The radioisotope lutetium-177 is at risk of slipping into shortage due to rapidly increasing demand, outdated manufacturing infrastructure and vulnerable supply chains, some radiopharma manufacturer …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Mustang Bio’s MB-108 receives FDA orphan drug status for glioma treatment

MB-108 is an oncolytic virus designed to treat malignant glioma. Credit: meeboonstudio via Shutterstock. Mustang Bio has received orphan drug designation from the US Food

November 8, 2024

30 Days, 30 Psychedelic Retreats – Lessons Learned From Our Quest to Study Central American Retreats and Their Potential to Heal Minds

BANG! The front axle of my front-wheel-drive car slams into an unmarked speedbump on Route 160 just outside of Paraiso, Costa Rica. Foolishly trying to

August 22, 2023

Pairing top-down and bottom-up approaches to gain insights into the origin of life

Despite decades of progress, the origin of life remains one of the great unsolved problems in science.

August 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.